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A B S T R A C T
Purpose: Focal cortical dysplasia (FCD) is the most common pathological diagnosis in patients who have
undergone surgical treatment for intractable neocortical epilepsy. However, presurgical identiﬁcation of
MRI abnormalities in FCD patients remains difﬁcult, and there are no highly sensitive imaging
parameters available that can reliably differentiate among FCD subtypes. The purpose of our study was
to investigate the surgical outcome in FCD patients with identiﬁable MRI abnormalities and to evaluate
the prognostic role of the various MRI features and the characteristics of FCD pathology.
Methods: We retrospectively recruited epilepsy patients who had undergone surgical treatment for
refractory epilepsywith focalMRI abnormalities and the pathological diagnosis of FCD.We evaluated the
surgical outcome according to the pathological subtypes, and studied the prognostic roles of variousMRI
features. We used recently proposed three-tiered FCD classiﬁcation system which included FCD type III
when FCD occurs in association with other potentially epileptogenic pathologies.
Results: A total of 69 patients were included, and 68.1% of patients became seizure free. Patients with
FCD type III had a lower chance for achieving seizure freedom (7/15) than in patients with isolated FCD
(FCD types I and II) (40/54, p = 0.044). Cortical thickness and blurring of gray–whitematter junctionwere
more common in isolated FCD than in FCD type III, but most MRI features failed to differentiate between
FCD types I and II, and only the transmantle sign was speciﬁc for FCD type II. We failed to ﬁnd a
prognostic value of speciﬁc MRI abnormalities of prognostic value in terms of post-epilepsy surgery
outcome in FCD patients.
Conclusions: Our study showed that patients with FCD III have poor surgical outcome. Typical MRI
features of isolated FCD such as cortical thickness and blurring of gray–white matter junction were less
common in FCD type III and only transmantle sign was helpful in differentiating between FCD types I
and II.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Surgical resection has been an important alternative treatment
for patients with intractable epilepsy. Although the EEG has an
essential role in the diagnosis and prediction of outcome in
epilepsy surgery, surgical outcome in patients without identiﬁable
lesion on presurgical MRI is less satisfactory than in patients with
MRI abnormalities, evenwith the precise focus localization on both
scalp and even invasive EEG monitoring.1,2 While the functional* Corresponding author at: Department of Neurology, Seoul National University
Hospital, 28, Yongkeun dong, Chongno Ku, Seoul 110-744, Republic of Korea.
Tel.: +82 2 20722923; fax: +82 2 36727553.
E-mail address: sangkun2923@gmail.com (S.K. Lee).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.09.006neuroimagings such as positron emission tomography (PET) and
single photon emission CT (SPECT) can improve the sensitivity of
detection of epileptogenic lesions, MRI is generally the imaging
technique of choice for identifying the structural basis of the
epilepsy.3–5 It may be difﬁcult to compare MRI with other
diagnostic modalities, but it is clear that the localization of a
lesion by MRI can both enhance conﬁdence and provide more
information than do PET or ictal SPECT, particularly when the
localization is supported by an electrophysiologic study.6
Focal cortical dysplasia (FCD) is the most common pathological
diagnosis in patients who underwent surgical treatment for
intractable neocortical epilepsy.7 Although the MRI characteristics
of FCD are a very important component of the clinical assess-
ment,8–10 the presurgical identiﬁcation of MRI abnormalities in
FCD patients remains difﬁcult, and there are no highly sensitivevier Ltd. All rights reserved.
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FCD subtypes. Furthermore, MRI frequently does not show any
abnormalities in patients with pathologically proven FCD,11 and
even in the presence of FCD, removal of the visual lesion along
frequently does not lead to a seizure free outcome, implicating that
the epileptogenic zone may extend beyond what can be visualized
with the current structural imaging modalities.
While a broad spectrum of histopathology can be found in
association with FCD,12–15 previous studies have focused on
describing the characteristics and surgical outcomes in patients
with isolated FCD,8,9,16,17 thus the surgical outcome and MRI
features in FCD with other epileptogenic pathologies are less well
documented. Recently, a new three-tiered classiﬁcation of FCDwas
proposed by the International League Against Epilepsy (ILAE).10 In
this new classiﬁcation, the deﬁnition of FCD types I and II is similar
with the previous ones, referring to the isolated FCDs that are not
adjacent to or associatedwith any other lesion. A novel FCD type III
refers to those variants with cortical dyslamination that are
adjacent to or associated with other potentially epileptogenic
lesions. The purpose of our study was to investigate the surgical
outcome in FCD patients with identiﬁable MRI abnormalities
according to the new ILAE classiﬁcation of FCD, and to evaluate the
prognostic role of various MRI features and the characteristics of
FCD pathology.
2. Methods
2.1. Patients
Our study included consecutive patients who had undergone
surgical treatment for refractory epilepsy, had presurgical MRI
abnormalities, and was conﬁrmed with pathological diagnosis of
FCD at the Seoul National University Hospital between November
1995 and June 2009. All patients had intractable epilepsy, despite
taking the appropriate anticonvulsant drugs. We only included
patients who underwent focal resection and excluded patients
with functional hemispherectomy or corpus callosotomy. Surgical
outcome was divided into seizure free and not seizure free.
2.2. Sequence of brain MRI and interpretation
All patients underwent brain MRI. Standard MRI was performed
on either a 1.5-T or a 3.0-T unit (Signa Advantages, General Electric
Medical Systems, Milwaukee, WI), with conventional spin-echo T1-
weightedsagittal andT2-weightedaxial andcoronal sequences inall
patients. The section thickness and the conventional image gaps
were 5 mm and 1 mm. T1-weighted 3D magnetization-prepared
rapid acquisition of gradient-echo sequences with 1.5 mm thick
sections of the whole brain and T2-weighted ﬂuid-attenuated
inversion recovery (FLAIR) images of 3 mm thick sections were also
obtained in the oblique coronal planeof the temporal lobe. The angle
of oblique coronal imagingwas perpendicular to the long axis of the
hippocampus. Spatial resolution was approximately 1.0 mm
1.0 mm (matrix, 256 mm 256mm; ﬁeld of view, 25 cm).
We excluded patients from the study when the MRI was
performed on a 1.0-T unit or it did not follow our MRI protocol for
epilepsy for decreased sensitivity. In particular, we analyzed the
frequency of several commonly documented MRI abnormalities in
FCD patients and studied their prognostic implications. The MRI
abnormalities included increased cortical thickness, blurring of the
gray–whitematter junction, increased cortical or subcortical signal
on the T2-weighted of FLAIR images, a radially oriented linear or
conical transmantle stripe of T2 hyperintensity (transmantle sign),
and localized cortical thinning or atrophy. Additionally, we studied
the presence of other MRI ﬁndings such as mass or cyst-like
appearance because these MRI ﬁndings were previously observedin pathologically conﬁrmed FCD patients, and occasionally found
in our surgical series of FCD.18,19
2.3. Video-EEG monitoring and functional neuroimaging
Interictal and ictal scalp EEGs were recorded in all patients
using a video-EEG monitoring system, with electrodes placed
according to the international 10–20 system, alongwith additional
anterior temporal electrodes. In patients for whom other methods
gave inconclusive or discordant results, we used a combination of
grids and strips for intracranial EEG. Grid and strip placements
were determined by the results of presurgical evaluations. At least
three habitual seizureswere recorded during scalp and intracranial
EEG monitoring. When necessary, preoperative and intraoperative
functional mapping and intraoperative electrocorticography were
also performed.
18F-ﬂuorodeoxyglucose PET was performed during the inter-
ictal period (no seizures for more than 24 h) and ictal SPECT was
performed during video-EEG monitoring. The detailed methods of
functional neuroimaging were described previously.6
2.4. Surgery and pathology
The surgical area was decided based on the clinical,
neuroimaging, and electrophysiological results. In our center,
the resection margin for epilepsy of neocortical origin with MRI
abnormalities was deﬁned by (A) the presence of either a
discrete lesion on MRI with compatible ictal EEG; and (B) the
absence of eloquent cortex.
Pathological ﬁndingswere classiﬁed according to the new ILAE
FCD classiﬁcation system. The new ILAE classiﬁcation for FCD
expands the Palmini classiﬁcation scheme with the addition of a
new type of FCD associated with a principal epileptogenic lesion.
In this system, FCD type I referred to isolated lesions of the
cerebral cortex, which presents as being either radial (FCD IA),
tangential (IB), or radial and tangential dyslamination (IC). FCD
type II referred to isolated lesions characterized by cortical
dyslamination and dysmorphic neuronswithout (FCD IIA) or with
balloon cells (IIB). FCD type III was deﬁned when FCD occurred in
combination with hippocampal sclerosis (HS) (FCD IIIA), with
epilepsy associated tumors (IIIB), with vascular malformation
(IIIC), and with epileptogenic lesions acquired in early life such as
traumatic injury, ischemic injury or encephalitis (IIID). Mild
malformation of cortical development (mMCD) referred to
pathologically mild malformation involving hypercellularity in
or outside layer I.
We excluded patients who had pathological evidence of brain
tumors in addition to FCD (FCD IIIB), due to the frequent overlap
between the pathology of several tumors and FCD, and the
limited amount of tissue available for assessment in some
patients.20 Furthermore, brain tumors themselves have charac-
teristic MRI ﬁndings and strong epileptogenecity, while our
study aimed to investigate the MRI features and surgical
outcomes according to the pathological subtypes in FCD
patients.21,22
2.5. Statistical tests
We compared the demographic data of the seizure free group
with the non-seizure free group and the clinical implications of
MRI features using the Student’s t-test or theMann–WhitneyU test
for continuous variables, and with a chi-square or Fisher’s exact
test for categorical variables.
All analyses were conducted using SPSS version 12.0 (SPSS Inc.,
Chicago, IL) and STATA version 9.2 (STATA Corp., College Station,
TX). p < 0.05 was considered signiﬁcant.
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3.1. Patients and surgical outcome
A total of 69 patients were included for the present study. The
subjects consisted of 46 men and 23 women, and the mean age of
the patients at the time of surgery was 34.6 (9.9) years (range 17–
55 years). Of the patients, 23 had frontal lobe epilepsy, 24 had
neocortical temporal lobe epilepsy, seven had parietal lobe epilepsy,
ﬁve had occipital lobe epilepsy, and 10 had multifocal epilepsy. The
proportion of seizure free patients was 66.7% (46/69) during the
follow-up for more than 2 years, whereas 33.3% (23/69) of patients
did not become seizure free.
3.2. Frequency of MRI abnormalities according to the pathological
subtypes of FCD
The most frequent MRI abnormalities were blurring of the
gray–white matter junction and cortical T2/FLAIR high signal
intensity, which were found in 33 patients (47.8%). Cortical
thinning or atrophy was found in 26 patients (37.7%), increased
cortical thickness was found in 32 patients (30.4%), and subcortical
T2/FLAIR high signal intensity was found in 12 patients (17.4%)
including 4 patients with the features of a transmantle sign (5.8%).
Eleven patients (15.9%) showed MRI abnormalities with mas or
cyst-like appearance, most commonly in themesial temporal areas
(Fig. 1). Interestingly, increased cortical thickness and blurring of
the gray–white matter junction frequently occurred together, and[(Fig._1)TD$FIG]
Fig. 1. IllustrativeMRI features in FCD patients. (A) Cortical high signal intensity on the FL
a patient with FCD IB; (C) cortical thickness, blurring of the gray–white matter junction
patient with FCD IIB; (D) cyst-like lesion on the T2-weighted image in a patient with FCD
the T2-weighted image in a patient with FCD IIIC (FCDwith angiomatosis); (F) cortical hig
patient with FCD IIID (FCD with traumatic lesion) FCD: focal cortical dysplasia, FLAIR:these combined MRI features were predictive of FCD IIB. We failed
to ﬁnd a prognostic value of speciﬁc MRI abnormalities on the
surgical outcome in FCD patients (Table 1), but complete resection
ofMRI abnormalities was associatedwith the seizure free outcome
(p = 0.05). PET and ictal SPECT were performed in 60 and 44
patients, respectively. The results of PET and ictal SEPCT and the
proportion of complete resection ofMRI lesionwere also presented
in Table 1.
3.3. Surgical outcome in different pathologic subtypes of FCD
Pathologically, 15 patients showed characteristics of FCD IA, 15
patients of FCD 1B, 9 patients of FCD IIA, 11 patients of FCD IIB, 6
patients of FCD IIIA, 3 patients of FCD IIIC, and 6 patients of FCD
IIID. We excluded patients with FCD IIIB from the study, and no
patient showed pathological characteristics of mMCD and FCD IC.
Excluding patients with adjacent epileptogenic pathology (FCD
type III), patients were divided into those with mild pathology
(FCD IA, and FCD IB) and those with severe pathology (FCD IIA, and
IIB). There was no difference in the surgical outcome between the
two groups (20/30 vs 20/24. p = 0.22), and the frequency of speciﬁc
MRI features was similar between the two groups, except for the
transmantle sign, which is well documented as being speciﬁc for
FCD II. When patients were divided into those with isolated
pathology (FCD types I and II) and those with adjacent pathology
(FCD type III), patients in the isolated pathology group had a
greater chance of becoming seizure free than did patients
with adjacent pathology group (14/54 vs 7/15, p = 0.044). SomeAIR image in a patient with FCD IA; (B)mass-like lesion on the T2-weighted image in
, and subcortical high signal intensity (transmantle sign) on the FLAIR image in a
IIIA (FCDwith hippocampal sclerosis); (E) subcortical high signal intensity lesion on
h signal intensity, cortical atrophy, and trauma-related scar on the FLAIR image in a
ﬂuid-attenuated inversion recovery.
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D.W. Kim et al. / Seizure 21 (2012) 789–794792FCD-speciﬁc MRI features, including increased cortical thickness
and blurring of the gray–white matter junction, were less frequent
in patients with FCD type III. One interesting ﬁnding is that cortical
thinning or atrophy was more frequent in FCD patients with
adjacent pathology than with isolated pathology and in the
isolated pathology group, it was more frequent in patients with
FCD type I than with FCD type II, although it did not reach
statistical signiﬁcance (Table 2).
4. Discussion
Forty-seven (68.1%) of 69 patients became seizure free after
surgical resection. The seizure free rate was better than those in
our previous studies with isolated FCD or FCD accompanied by HS
as dual pathology.6,23 This result can be explained by the inclusion
of patients with identiﬁable MRI lesions, because the presence of
MRI abnormality is an important prognostic factor of epilepsy
surgery in FCD patients. A previous study observed that the
appearance of the blurring the gray–white matter junction was
associated with favorable surgical outcome,17 however, we could
not conﬁrm this result. Even the transmantle sign, which is speciﬁc
for FCD type II,8,24–26 was not a predictor of a favorable surgical
outcome. This result may be related to the limited number of
patients because the positive prognostic effect of severe patholog-
ical features has been documented in previous studies including
our study.6,26,27 One interesting ﬁnding in our studywas the poorer
surgical outcome in patients with FCD type III than with isolated
FCD (FCD types I and II). The difference in prognosis can mostly be
attributable to the disappointingly low chance of seizure free
outcome in FCD type III. However, it is hard to evaluate the clinical
implication of our results because we included only 15 patients
with FCD type III, the surgical outcome would be variable among
the subtypes of FCD type III, and there are only limited studies on
the surgical outcome in FCD III patients.17,28
A previous study documented that increased cortical thickness
and gray matter signal abnormality were more common in FCD
type II.8 Our study found that increased cortical thickness and
blurring of the gray–white matter junction were relatively
common ﬁndings in FCD type II. In parallel with previous studies,
the transmantle sign was encountered exclusively in FCD type II
patients,8,24–26 However, with the low incidence of the transman-
tle sign, we failed to identify reliable MRI features which could be
helpful in differentiating between FCD types I and II. On the other
hand, there was a marked difference in the MRI features between
the isolated FCD and FCD type III. While cortical thinning or
atrophy was a relative common MRI ﬁnding in FCD type III,
increased cortical thickness and blurring of gray–white matter
junction were remarkably rare ﬁndings in FCD type III, although
these MRI features have been considered as typical for FCD.
Interestingly, cortical thinning or atrophy was a frequent MRI
ﬁnding in one study with FCD patients with a history of prenatal
and perinatal injury.29 Since the study was performed before the
introduction of new ILAE classiﬁcation for FCD, the pathological
degree was graded as mMCD or FCD type I. However, it is probable
that most patients with prenatal and perinatal brain injury can be
re-classiﬁed as FCD type III with new ILAE classiﬁcation, and
moreover, the observation would be consistent with our results
stating that cortical thinning or atrophy is a common MRI ﬁnding
in FCD type III. Another interesting ﬁnding in our study is the
presence of mass or cyst-like lesions in FCD patients. The mass or
cyst-like lesions on MRI have a prediction for the mesial temporal
areas, but we could not ﬁnd the reason of this prediction for mesial
temporal areas. The MRI features in this group can be described as
cortical thickness or increased cortical or subcortical signal
intensity, but we think that this MRI feature is worth documenting
separately as another MRI feature in FCD patients, because the
Table 2
Demographic features, surgical outcomes and the frequency of MRI abnormalities according to the subgroups of FCD.
FCD I (N=30) FCD II (N=24) p-Value Isolated FCD (FCD I
and II) (N=15)
FCD III (N=54) p-Value
Age at operation 29.014.2 25.514.2 0.80 27.514.1 36.59.8 0.023
Male 18 15 0.85 33 13 0.07
Increased cortical thickness 9 12 0.13 21 0 0.003
Blurring of gray–white matter junction 14 16 0.14 30 3 0.02
Increased cortical signal intensity 14 11 0.95 25 8 0.63
Increased subcortical signal intensity 5 6 0.45 11 1 0.44
Mass or cyst-like appearance 5 3 0.72 8 3 0.69
Cortical atrophy 13 5 0.08 18 8 0.15
Transmantle sign 0 4 0.03 4 0 0.57
Seizure free outcome 20 20 0.22 40 7 0.044
FCD, focal cortical dysplasia; N, number of patients.
D.W. Kim et al. / Seizure 21 (2012) 789–794 793clinical features and MRI ﬁndings were largely indistinguishable
from those of benign brain tumors.19,21,30 Although we did not
exclude patients with mMCD pathology, there was no patient with
mMCD pathology with the correspondingMRI abnormality. Due to
the fact that mMCD is deﬁned as a pathologically mild malforma-
tion involving hypercellularity in or outside layer I, these
pathological features are reasonably not visible using the current
MRI technique.
The pathological features of FCD type III are not quite different
from the isolated FCD type I.10 FCD IIIA is deﬁned when the
temporal cortex shows alternations in architectural organization
or cytoarchitectural composition in combination with HS. This
subtype does not include the dual pathology condition, which is
when patients with HS have a second principal lesion affecting the
brain, including FCD type II.10 Although several reports have
described the presence of dysplastic lesions in patients with HS as
being associated with early seizure onset, high seizure frequency,
and poor surgical outcomes,31–33 the clinical implications of the
dysplastic lesions in patients with HS are still controversial.34,35
While FCD IIIC is deﬁned when alterations in architectural or
cytoarchitectural composition occur adjacent to various vascular
malformations, there are only limited reports on the FCD IIIC,36,37
with even fewer surgical cases.38,39 Considering the strong
epileptogenecity of some vascular malformations, the apparent
architectural change may be acquired secondary to the develop-
ment of the principal lesion.10,40 FCD IIID refers to the altered
architectural or cytoarchitectural composition of the neocortex,
adjacent to other lesions acquired during early life. These lesions
comprised a large spectrum, including traumatic brain injury,
prenatal or perinatal vascular events and inﬂammatory or
infectious diseases.12,13,16,41,42 The re-organization of the cortical
cytoarchitecture can also be acquired secondary to the develop-
ment of other epileptogenic pathologies. Interestingly, the
evidence of coexistent perinatal or perinatal injuries was
frequently found in several pathological and clinical studies with
a mild degree of FCD,14,29 thus, it is possible that the prenatal or
perinatal injuries may be a common cause of the development of
FCD, particularly for themild pathological degree includingmMCD
and FCD type I as well as FCD type III.
Our study suggests that the surgical outcome would be less
favorable in FCD type III patients, and careful investigation should
be considered in these patients. Typical MRI features of FCD types I
and II, such as cortical thickness and blurring of the gray–white
matter junction, were less common in FCD type III whereas cortical
thinning or atrophy was relatively common in FCD type III. Most
MRI features failed to differentiate between FCD types I and II, but
only the transmantle sign was speciﬁc for FCD types II. However,
since we studied only a limited number of patients, further studies
are needed in order to completely understand the surgical outcome
and MRI features in FCD patients.Acknowledgements
This work was supported by the National Research Foundation
of Korea (NRF) grant funded by the Korea Government (2011-
0016634). DW Kim was supported by Basic Science Research
Program through the National Research Foundation of Korea (NRF)
funded by the Ministry of Education, Science and Technology
(grant number: 2012R1A1A1001850).
References
1. Dworetzky BA, Reinsberger C. The role of the interictal EEG in selecting
candidates for resective epilepsy surgery. Epilepsy & Behavior 2011;20:167–71.
2. Jackson GD, Badawy RA. Selecting patients for epilepsy surgery: identifying a
structural lesion. Epilepsy & Behavior 2011;20:182–9.
3. Koepp MJ, Woermann FG. Imaging structure and function in refractory focal
epilepsy. Lancet Neurology 2005;4:42–53.
4. Widdess-Walsh P, Diehl B, Najm I. Neuroimaging of focal cortical dysplasia.
Journal of Neuroimaging 2006;16:185–96.
5. Wehner T, Luders H. Role of neuroimaging in the presurgical evaluation of
epilepsy. Journal of Clinical Neurology 2008;4:1–16.
6. Kim DW, Lee SK, Chu K, Park KI, Lee SY, Lee CH, et al. Predictors of surgical
outcome and pathologic considerations in focal cortical dysplasia. Neurology
2009;72:211–6.
7. Yun CH, Lee SK, Lee SY, Kim KK, Jeong SW, Chung CK. Prognostic factors in
neocortical epilepsy surgery: multivariate analysis. Epilepsia 2006;47:574–9.
8. Krsek P, Maton B, Korman B, Pacheco-Jacome E, Jayakar P, Dunoyer C, et al.
Different features of histopathological subtypes of pediatric focal cortical
dysplasia. Annals of Neurology 2008;63:758–69.
9. Lerner JT, Salamon N, Hauptman JS, Velasco TR, Hemb M, Wu JY, et al. Assess-
ment and surgical outcomes formild type I and severe type II cortical dysplasia:
a critical review and the UCLA experience. Epilepsia 2009;50:1310–35.
10. Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, et al. The
clinicopathologic spectrum of focal cortical dysplasias: a consensus classiﬁca-
tion proposed by an ad hoc Task Force of the ILAE Diagnostic Methods
Commission. Epilepsia 2011;52:158–74.
11. Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK. Surgical outcome and
prognostic factors of cryptogenic neocortical epilepsy. Annals of Neurology
2005;58:525–32.
12. Lombroso CT. Can early postnatal closed head injury induce cortical dysplasia.
Epilepsia 2000;41:245–53.
13. Marin-Padilla M, Parisi JE, Armstrong DL, Sargent SK, Kaplan JA. Shaken infant
syndrome: developmental neuropathology, progressive cortical dysplasia, and
epilepsy. Acta Neuropathologica 2002;103:321–32.
14. Prayson RA, Frater JL. Cortical dysplasia in extratemporal lobe intractable
epilepsy: a study of 52 cases. Annals of Diagnostic Pathology 2003;7:139–46.
15. Spreaﬁco R, Blumcke I. Focal cortical dysplasias: clinical implication of neuro-
pathological classiﬁcation systems. Acta Neuropathologica 2010;120:359–67.
16. Kim DW, Kim KK, Chu K, Chung CK, Lee SK. Surgical treatment of delayed
epilepsy in hemiconvulsion-hemiplegia-epilepsy syndrome. Neurology
2008;70:2116–22.
17. Chang EF, Wang DD, Barkovich AJ, Tihan T, Auguste KI, Sullivan JE, et al.
Predictors of seizure freedom after surgery for malformations of cortical
development. Annals of Neurology 2011;70:151–62.
18. Lehericy S, Dormont D, Semah F, Clemenceau S, Granat O, Marsault C, et al.
Developmental abnormalities of the medial temporal lobe in patients with
temporal lobe epilepsy. American Journal of Neuroradiology 1995;16:617–26.
19. Modha A, Vassilyadi M, Keene D, Jimenez C, Michaud J, Matzinger MA, et al.
Temporal lobe focal cortical dysplasia: MRI imaging using FLAIR shows lesions
consistent with neoplasia. Childs Nervous System 2000;16:269–77.
20. Prayson RA, Fong J, Najm I. Coexistent pathology in chronic epilepsy patients
with neoplasms. Modern Pathology 2010;23:1097–103.
D.W. Kim et al. / Seizure 21 (2012) 789–79479421. Phi JH, Kim SK, Cho BK, Lee SY, Park SY, Park SJ, et al. Long-term surgical
outcomes of temporal lobe epilepsy associated with low-grade brain tumors.
Cancer 2009;115:5771–9.
22. Chang EF, Christie C, Sullivan JE, Garcia PA, Tihan T, Gupta N, et al. Seizure
control outcomes after resection of dysembryoplastic neuroepithelial tumor in
50 patients. Journal of Neurosurgery Pediatrics 2010;5:123–30.
23. Kim DW, Lee SK, Nam H, Chu K, Chung CK, Lee SY, et al. Epilepsy with dual
pathology: surgical treatment of cortical dysplasia accompanied by hippocam-
pal sclerosis. Epilepsia 2010;51:1429–35.
24. Barkovich AJ, Kuzniecky RI, Bollen AW, Grant PE. Focal transmantle dysplasia:
a speciﬁc malformation of cortical development. Neurology 1997;49:
1148–52.
25. Urbach H, Schefﬂer B, Heinrichsmeier T, von Oertzen J, Kral T, Wellmer J, et al.
Focal cortical dysplasia of Taylor’s balloon cell type: a clinicopathological entity
with characteristic neuroimaging and histopathological features, and favorable
postsurgical outcome. Epilepsia 2002;43:33–40.
26. Widdess-Walsh P, Kellinghaus C, Jeha L, Kotagal P, Prayson R, Bingaman W,
et al. Electro-clinical and imaging characteristics of focal cortical dysplasia:
correlation with pathological subtypes. Epilepsy Research 2005;67:25–33.
27. Tassi L, ColomboN, Garbelli R, Francione S, Lo RussoG,Mai R, et al. Focal cortical
dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical out-
come. Brain 2002;125:1719–32.
28. Tassi L, Garbelli R, Colombo N, Bramerio M, Lo Russo G, Deleo F, et al. Type I
focal cortical dysplasia: surgical outcome is related to histopathology. Epileptic
Disorders 2010;12:181–91.
29. Krsek P, Jahodova A, Maton B, Jayakar P, Dean P, Korman B, et al. Low-grade
focal cortical dysplasia is associated with prenatal and perinatal brain injury.
Epilepsia 2010;51:2440–8.
30. Soeder BM, Gleissner U, Urbach H, Clusmann H, Elger CE, Vincent A, et al.
Causes, presentation and outcome of lesional adult onset mediotemporal lobe
epilepsy. Journal of Neurology Neurosurgery and Psychiatry 2009;80:894–9.
31. Engel Jr J. Update on surgical treatment of the epilepsies. Clinical and Experi-
mental Neurology 1992;29:32–48.32. Bocti C, Robitaille Y, Diadori P, Lortie A, Mercier C, Bouthillier A, et al. The
pathological basis of temporal lobe epilepsy in childhood. Neurology
2003;60:191–5.
33. Kelemen A, Barsi P, Eross L, Vajda J, Czirjak S, Borbely C, et al. Long-term
outcome after temporal lobe surgery—prediction of late worsening of seizure
control. Seizure 2006;15:49–55.
34. Kasper BS, Stefan H, Paulus W. Microdysgenesis in mesial temporal lobe
epilepsy: a clinicopathological study. Annals of Neurology 2003;54:501–6.
35. Kalnins RM, McIntosh A, Saling MM, Berkovic SF, Jackson GD, Briellmann RS.
Subtle microscopic abnormalities in hippocampal sclerosis do not predict
clinical features of temporal lobe epilepsy. Epilepsia 2004;45:940–7.
36. Abe T, Singer RJ, Marks MP, Kojima K, Watanabe M, Uchida M, et al. Arterial
vascular abnormality accompanying cerebral cortical dysplasia. AJNR American
Journal of Neuroradiology 1997;18:144–6.
37. Cui Z, Luan G. A venous malformation accompanying focal cortical dysplasia
resulting in a reorganization of language-eloquent areas. Journal of Clinical
Neuroscience 2011;18:404–6.
38. Giulioni M, Zucchelli M, Riguzzi P, Marucci G, Tassinari CA, Calbucci F. Co-
existence of cavernoma and cortical dysplasia in temporal lobe epilepsy. Journal
of Clinical Neuroscience 2007;14:1122–4.
39. Maciunas JA, Syed TU, Cohen ML, Werz MA, Maciunas RJ, Koubeissi MZ. Triple
pathology in epilepsy: coexistence of cavernous angiomas and cortical dyspla-
sias with other lesions. Epilepsy Research 2010;91:106–10.
40. Ferrier CH, Aronica E, Leijten FS, Spliet WG, Boer K, van Rijen PC, et al.
Electrocorticography discharge patterns in patients with a cavernous heman-
gioma and pharmacoresistent epilepsy. Journal of Neurosurgery 2007;107:495–
503.
41. Hart YM, Andermann F, Robitaille Y, Laxer KD, Rasmussen T, Davis R. Double
pathology in Rasmussen’s syndrome: a window on the etiology? Neurology
1998;50:731–5.
42. Kremer S, De Saint Martin A, Minotti L, Grand S, Benabid AL, Pasquier B, et al.
Focal cortical dysplasia possibly related to a probable prenatal ischemic injury.
Journal of Neuroradiology Journal de Neuroradiologie 2002;29:200–3.
